PMC:7361216 / 0-439 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":2,"end":7},"obj":"Body_part"},{"id":"T2","span":{"begin":209,"end":212},"obj":"Body_part"},{"id":"T3","span":{"begin":237,"end":243},"obj":"Body_part"},{"id":"T4","span":{"begin":384,"end":387},"obj":"Body_part"},{"id":"T5","span":{"begin":414,"end":427},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62977"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":237,"end":243},"obj":"Body_part"},{"id":"T2","span":{"begin":414,"end":427},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":40,"end":58},"obj":"Disease"},{"id":"T2","span":{"begin":356,"end":374},"obj":"Disease"},{"id":"T3","span":{"begin":388,"end":409},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004960"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":33,"end":34},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":68,"end":69},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":84,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5","span":{"begin":115,"end":116},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6","span":{"begin":349,"end":350},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T7","span":{"begin":414,"end":427},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T8","span":{"begin":436,"end":437},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":250,"end":257},"obj":"Chemical"},{"id":"T2","span":{"begin":267,"end":279},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_53590"},{"id":"A3","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_61420"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T1","span":{"begin":51,"end":58},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T2","span":{"begin":367,"end":374},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-CHEBI

    {"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T1","span":{"begin":267,"end":279},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_53590"},{"id":"A2","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_61420"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":139,"end":147},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":148,"end":316},"obj":"Sentence"},{"id":"T3","span":{"begin":317,"end":325},"obj":"Sentence"},{"id":"T4","span":{"begin":327,"end":335},"obj":"Sentence"},{"id":"T5","span":{"begin":336,"end":344},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-PD-UBERON

    {"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T1","span":{"begin":237,"end":243},"obj":"Body_part"},{"id":"T2","span":{"begin":414,"end":427},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"4","span":{"begin":40,"end":58},"obj":"Disease"},{"id":"3","span":{"begin":86,"end":98},"obj":"Chemical"},{"id":"5","span":{"begin":139,"end":147},"obj":"Disease"},{"id":"53","span":{"begin":356,"end":374},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"pubann:denotes","subj":"4","obj":"MESH:D020271"},{"id":"A5","pred":"pubann:denotes","subj":"5","obj":"MESH:C000657245"},{"id":"A53","pred":"pubann:denotes","subj":"53","obj":"MESH:D020271"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-UniProt

    {"project":"LitCovid-sample-UniProt","denotations":[{"id":"T1","span":{"begin":205,"end":208},"obj":"Protein"}],"attributes":[{"id":"A1","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q567S4"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":2,"end":7},"obj":"Body_part"},{"id":"T2","span":{"begin":209,"end":212},"obj":"Body_part"},{"id":"T3","span":{"begin":237,"end":243},"obj":"Body_part"},{"id":"T4","span":{"begin":384,"end":387},"obj":"Body_part"},{"id":"T5","span":{"begin":414,"end":427},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62977"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T1","span":{"begin":40,"end":58},"obj":"Disease"},{"id":"T2","span":{"begin":139,"end":147},"obj":"Disease"},{"id":"T3","span":{"begin":356,"end":374},"obj":"Disease"},{"id":"T4","span":{"begin":388,"end":409},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0004960"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":148,"end":316},"obj":"Sentence"},{"id":"T3","span":{"begin":317,"end":325},"obj":"Sentence"},{"id":"T4","span":{"begin":327,"end":335},"obj":"Sentence"},{"id":"T5","span":{"begin":336,"end":344},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":86,"end":98},"obj":"Chemical"},{"id":"4","span":{"begin":40,"end":58},"obj":"Disease"},{"id":"5","span":{"begin":139,"end":147},"obj":"Disease"},{"id":"53","span":{"begin":356,"end":374},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"MESH:D020271"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:C000657245"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D020271"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19\nAn Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021\nSTEINMAN\n\nAbstract\nAbstract\n\nIn a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a s"}